Platelet genetic biomarker quantification: Comparison of fluorescent microspheres and PCR platforms

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Issue: 2013: 109/2 (Feb) pp. 175-360
Pages: 337-346

  1. Stenberg PE, Hill RL. Platelets and megakaryocytes. In: Wintrobe's Clinical Hematology. Philadelphia: Linnincott William Wilkins; 1999. pp. 615-660
  2. Newman P, Gorski J, White G, Gidwitz S, Cretney C, Aster R. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988; 82: 739-743. DOI:10.1172/JCI113656
  3. Levin J. The evolution of mammalian platelets. In: Platelets. Second ed: Elsevier; 2007. pp. 3-23
  4. Fink L, Holschermann H, Kwapiszewska G, et al. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost. 2003; 90: 749-756.
  5. Rinder H, Schuster J, Rinder C, et al. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 1998; 91: 1288-1294.
  6. Gnatenko DV, Perrotta PL, Bahou WF. Proteomic approaches to dissect platelet function: one-half of the story. Blood 2006; 108: 3983-3991. DOI:10.1182/blood-2006-06-026518
  7. Gnatenko DV, Bahou WF. Recent advances in platelet transcriptomics. Transfus Med Hemother 2006; 33: 217-226. DOI:10.1159/000091371
  8. Dittrich M, Birschmann I, Pfrang J, et al. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost 2006; 95: 643-651.
  9. Gnatenko DV, Dunn JJ, McCorkle SR, et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285-2293. DOI:10.1182/blood-2002-09-2797
  10. Bugert P, Dugrillon A, Gunaydin A, et al. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 2003; 90: 738-748.
  11. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 2004; 3: 133-144.
  12. Gnatenko DV, Cupit LD, Huang EC, et al. Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 2005; 94: 412-421.
  13. Shim MH, Hoover A, Blake N, et al. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 2004; 32: 638-648. DOI:10.1016/j.exphem.2004.04.002
  14. Tenedini E, Fagioli ME, Vianelli N, et al. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood 2004; 104: 3126-3135. DOI:10.1182/blood-2003-07-2597
  15. Rowley JW, Oler AJ, Tolley ND, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118: e101-111. DOI:10.1182/blood-2011-03-339705
  16. Cecchetti L, Tolley ND, Michetti N, et al. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood 2011; 118: 1903-1911. DOI:10.1182/blood-2010-12-324517
  17. Kieffer N, Guichard J, Farcet JP, et al. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem. 1987; 164: 189-195. DOI:10.1111/j.1432-1033.1987.tb11010.x
  18. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25: 489-495. DOI:10.1016/
  19. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122: 379-391. DOI:10.1016/j.cell.2005.06.015
  20. Senzel L, Gnatenko D, Bahou W. Platelet transcriptome and cardiovascular disease. Future Cardiol 2007; 3: 391-398. DOI:10.2217/14796678.3.4.391
  21. Gnatenko DV, Zhu W, Bahou WF. Multiplexed genetic profiling of human blood platelets using fluorescent microspheres. Thromb Haemost 2008; 100: 929-936.
  22. Gnatenko DV, Zhu W, Xu X, et al. Class prediction models of thrombocytosis using genetic biomarkers. Blood 2010; 115: 7-14. DOI:10.1182/blood-2009-05-224477
  23. Kriegova E, Arakelyan A, Fillerova R, et al. PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. BMC Mol Biol 2008; 9: 69. DOI:10.1186/1471-2199-9-69
  24. de Jonge HJM, Fehrmann RSN, de Bont ESJM, et al. Evidence Based Selection of Housekeeping Genes. PloS one 2007; 2: e898. DOI:10.1371/journal.pone.0000898
  25. Ludbrook J. Linear regression analysis for comparing two measurers or methods of measurement: But which regression? Clin Exp Pharmacol Physiol 2010; 37: 692-699. DOI:10.1111/j.1440-1681.2010.05376.x
  26. Linnet K. Evaluation of regression procedures for methods comparison studies. Clin Chem 1993; 39: 424-432.
  27. Canales RD, Luo Y, Willey JC, et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nature Biotechnol 2006; 24: 1115-1122. DOI:10.1038/nbt1236
  28. Murphy S, Peterson P, Iland H, et al. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Sem Hematol 1997; 34: 29-39.
  29. Freedman JE, Larson MG, Tanriverdi K, et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010; 122: 119-129. DOI:10.1161/CIRCULATIONAHA.109.928192
  30. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68-74. DOI:10.1038/nm0102-68
  31. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98: 13790-13795. DOI:10.1073/pnas.191502998
  32. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1: 203-209. DOI:10.1016/S1535-6108(02)00030-2
  33. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87. DOI:10.1016/S1535-6108(02)00018-1
  34. Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54. DOI:10.1038/ng1060
  35. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779-1790. DOI:10.1056/NEJMoa051113
  36. Finazzi G, Harrison C. Essential thrombocythemia. Semin Hematol 2005; 42: 230-238. DOI:10.1053/j.seminhematol.2005.05.022
  37. Yang M, Rajan S, Issa AM. Cost effectiveness of gene expression profiling for early stage breast cancer: A decision-analytic model. Cancer 2012; Epub ahead of print

You may also be interested in...


Dmitri V. Gnatenko1, Wei Zhu2, Wadie F. Bahou1,3

Thromb Haemost 2008 100 5: 929-936


Online Supplementary Material

H. Plé (1, 2), M. Maltais (3), A. Corduan (1, 2), G. Rousseau (3), F. Madore (3), P. Provost (1, 2)

Thromb Haemost 2012 108 4: 605-615


Sasidhar Guthikonda1, Kirankumar Mangalpally1, Muthiah Vaduganathan1, Rajnikant Patel2, Timothy DeLao1, Angela L. Bergeron3, Jing-Fei Dong3, Eli I. Lev1, Neal S. Kleiman1

Thromb Haemost 2008 100 1: 83-89

Thrombosis News

Mobile technology identifies people with unknown atrial fibrillation at high risk of stroke – article published in Thrombosis and Haemostasis

The article “Feasibility and cost effectiveness of stroke prevention through community screening...

TH 111.4

The April 2014 TH 111.4 issue of Thrombosis and Haemostasis is a Theme Issue by Guest Editor B....

TH 111.3

Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...